Alnylam Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Period Activity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. RTX
8. SMCI
9. S
10. COF

Go back to Alnylam Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Period Activity

Alnylam Pharmaceuticals (ALNY) PT Raised to $128 at BMO Capital

May 1, 2019 12:59 PM EDT

BMO Capital analyst Do Kim raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $128.00 (from $126.00) while maintaining a Outperform rating following Q1 results.

The analyst commented, "We raise our Onpattro projections and target price to $128 from $126, as 1Q19 sales beat our and... More

Alnylam Pharma (ALNY) Tops Q1 EPS by 65c

May 1, 2019 8:06 AM EDT

Alnylam Pharma (NASDAQ: ALNY) reported Q1 EPS of ($1.42), $0.65 better than the analyst estimate of ($2.07). Revenue for the quarter came in at $33.3 million versus the consensus estimate of $23.65 million.

2019 Updated Financial Guidance


Alnylam is updating its 2019 annual non-GAAP R&D... More